BIO-TECHNE Corp (TECH) insider trading.
In Q3 2026, insiders at BIO-TECHNE Corp reported 22 non-derivative transactions on 17 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 22
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 8
- Last filed
- 2026-09-30
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Bohnen Shane | Officer · SVP - General Counsel | 4 | 0 | 0 |
| Hippel James | Officer · CFO | 4 | 0 | 0 |
| Kelderman Kim | Director, Officer · Chief Executive Officer | 4 | 0 | 0 |
| Higgins John L | Director | 2 | 0 | 0 |
| Baumgartner Robert V | Director | 2 | 0 | 0 |
| Herr Amy E. | Director | 2 | 0 | 0 |
| Crouse Steven C. | Officer · President - Diag & Spatial Bi | 2 | 0 | 0 |
| Geist William | Officer · PRESIDENT, PROTEIN SCIENCES | 2 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-28 | Higgins John L | M (A) | 15,940 | $0 | 82,816 | Form 4 |
| 2026-09-28 | Higgins John L | F (D) | 5,562 | $72.51 | 77,254 | Form 4 |
| 2026-09-22 | Baumgartner Robert V | M (A) | 15,940 | $0 | 62,443 | Form 4 |
| 2026-09-22 | Baumgartner Robert V | F (D) | 5,559 | $72.55 | 56,884 | Form 4 |
| 2026-08-15 | Herr Amy E. | M (A) | 589 | $0 | 789 | Form 4 |
| 2026-08-15 | Herr Amy E. | F (D) | 213 | $72.4 | 576 | Form 4 |
| 2026-08-15 | Crouse Steven C. | F (D) | 1,947 | $72.4 | 10,237 | Form 4 |
| 2026-08-15 | Crouse Steven C. | M (A) | 5,423 | $0 | 12,184 | Form 4 |
| 2026-08-15 | Bohnen Shane | F (D) | 1,343 | $72.4 | 10,360 | Form 4 |
| 2026-08-15 | Bohnen Shane | M (A) | 4,350 | $0 | 11,703 | Form 4 |
| 2026-08-15 | Geist William | M (A) | 6,416 | $0 | 26,919 | Form 4 |
| 2026-08-15 | Geist William | F (D) | 1,976 | $72.4 | 24,943 | Form 4 |
| 2026-08-15 | Hippel James | M (A) | 9,779 | $0 | 174,493 | Form 4 |
| 2026-08-15 | Hippel James | F (D) | 4,310 | $72.4 | 170,183 | Form 4 |
| 2026-08-15 | Kelderman Kim | M (A) | 21,470 | $0 | 93,583 | Form 4 |
| 2026-08-15 | Kelderman Kim | F (D) | 10,821 | $72.4 | 82,762 | Form 4 |
| 2026-07-29 | Hippel James | F (D) | 51,024 | $72.03 | 164,714 | Form 4 |
| 2026-07-29 | Hippel James | M (A) | 62,068 | $47.6 | 215,738 | Form 4 |
| 2026-07-28 | Kelderman Kim | M (A) | 35,000 | $47.6 | 100,799 | Form 4 |
| 2026-07-28 | Kelderman Kim | F (D) | 28,686 | $72.07 | 72,113 | Form 4 |
| 2026-07-23 | Bohnen Shane | M (A) | 448 | $47.6 | 7,697 | Form 4 |
| 2026-07-23 | Bohnen Shane | F (D) | 344 | $71.77 | 7,353 | Form 4 |
Transaction codes in this quarter
Get TECH insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=842023&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · TECH company page · BIO-TECHNE Corp on SEC.gov
Questions
Are insiders buying or selling BIO-TECHNE Corp (TECH)?
In Q3 2026, insiders at BIO-TECHNE Corp reported 22 non-derivative transactions on 17 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these BIO-TECHNE Corp insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/tech.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.